2.5 MM Turbo Clirpath Excimer Laser Catheter, Model 225-011
Catheter For Crossing Total Occlusions. 510(k) K043465, from Spectranetics Corp. (Colorado Springs, CO). Product code PDU, class 2.
As of Nov 19, 2026, K043465 is an FDA 510(k) held by Spectranetics Corp., substantially equivalent on Aug 18, 2005 after 246 days, with no recalls tied to it in FDA's recall database.
- Review time: 246 days
- Recalls: 0
- Cited as a predicate by: 2 devices
For use in the endovascular treatment of symptomatic infrainguinal lower extremity vascular disease where total obstructions can not be crossed with standard guide wires.
- Clirpath Excimer Laser CatheterK040067 · Spectranetics Corp. · Apr 27, 2004
- Clirpath Turbo Plus Excimer Laser Catheters, Models 314-151, 314-159, 317-152, 317-156, 320-006, 320-159, 323-001K052514 · Spectranetics Corp. · Oct 19, 2005
- Clirpath Turbo Excimer Laser CathetersK052296 · Spectranetics Corp. · Sep 2, 2005
- Kiba CTO Crossing CatheterK262013 · Reflow Medical, Inc. · Aug 28, 2026
- Santreva™-ATK Endovascular Revasculariztion CatheterK252315 · AngioSafe, Inc. · Sep 22, 2025
- LimFlow ARCK251376 · LimFlow, Inc. · May 31, 2025
- SoundBite® Crossing System XS PeripheralK230159 · Soundbite Medical Solutions, Inc. · Aug 28, 2023
- Tigereye ST CTO-Crossing CatheterK230594 · Avinger, Inc. · Apr 25, 2023
- Tunnel Crossing CatheterK221163 · Tractus Vascular, LLC · Jan 19, 2023
- LimFlow ARCK221541 · LimFlow, Inc. · Aug 31, 2022
- DABRA Excimer Laser System (DABRA Laser model RA-308 and DABRA Catheter model 2.0)K220544 · Ra Medical Systems,Inc · Jun 29, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Dec 15, 2004
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.1250
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files